Sources

10 Total Sources

Daraxonrasib Doubles Stage 4 Pancreatic Cancer Survival as FDA Reviews July 22 Application

New Drug Daraxonrasib Doubles Pancreatic Cancer Survival, Seeks FDA Approval

Medical Daily9d ago

A New Pancreatic Cancer Drug Is Reaching Patients Before Approval and the Testing Rules Are Not What Many Assume

blackdoctor.pro9d ago

Daraxonrasib Extends Survival in Previously Treated Metastatic Pancreatic Cancer - BlackDoctor Pro

Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib

IFLScience9d ago

New Once-Daily Pill That Almost Doubles Survival Time For Patients With Advanced Pancreatic Cancer Applauded By Medical Experts | IFLScience

Stanford Medical Center Report9d ago

Stanford expands access to revolutionary pancreatic cancer drug | Stanford Cancer Institute

USA TODAY8d ago

Daraxonrasib Pancreatic Cancer Drug Available via FDA Program After Doubling Survival

Instagram9d ago

The results presented at the American Society of Clinical Oncology (ASCO) Annual Meeting #ASCO26 for daraxonrasib represent the most significant advance we have ever seen in #pancreaticcancer. For a disease that has

tiktok.com9d ago

Daraxonrasib for Pancreatic Cancer: Survival Benefits & Side Effects | TikTok

Chicago Tribune9d ago

Illinois patients starting to receive pancreatic cancer drug